This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Authoring team

Prognostic factors in necrotising fasciitis include: (1)

  • extent of infection
  • delayed first debridement
  • multi-organ dysfunction or systemic inflammatory response at presentation
  • diabetes mellitus
  • peripheral vascular disease
  • malnutrition
  • malignancy
  • immunocompromised states eg HIV/AIDS, steroids, cytotoxics
  • obesity
  • chronic alcoholism
  • IV drug abuse

One study of NF affecting upper or lower limbs found 22.3% underwent amputation or disarticulation of a limb following failure of multiple debridement attempts to control infection. (2)

Mortality from necrotising fasciitis properly treated with surgery plus antibiotics has been estimated at between 10% and 40%. Mortality is higher in patients who develop shock and end-organ damage - approaching 50% to 70% (3)

Reference:

  1. Diab J et al. Necrotising fasciitis. BMJ 2020;369:m1428.
  2. Angoules AG, Kontakis G, Drakoulakis E, et al; Necrotising fasciitis of upper and lower limb: a systematic review. Injury. 2007 Dec;38 Suppl 5:S19-26
  3. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.